News|Articles|August 28, 2018

Pfizer Recalls Children’s Advil

Pfizer Consumer Healthcare is recalling one lot of Children’s Advil Suspension Bubble Gum Flavored 4 FL OZ Bottle because of improperly marked dosage cups.

On Aug. 27, 2018, Pfizer Consumer Healthcare, a division of Pfizer Inc., announced it was voluntarily recalling one lot of Children’s Advil Suspension Bubble Gum Flavored 4 FL OZ Bottle. The recall was initiated after customers complained that the dosage cup provided is marked in teaspoons but the instructions on the label are described in milliliters (mL). The recalled product, NDC 0573-0207-30, lot R51129, was distributed nationwide from May–June 2018.

Children’s Advil Suspension Bubble Gum Flavored 4 FL OZ Bottle temporarily reduces fever and relieves minor aches and pains due to the common cold, flu, sore throat, headaches and toothaches. According to the company, the difference in measurements listed may potentially result in an overdose, which could cause nausea, vomiting, headache, drowsiness, blurred vision, and dizziness.

Source: FDA

 


Related to this article

PharmTech Weekly Roundup—October 2, 2026
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.